Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022

被引:0
|
作者
Surie, Diya [1 ]
Bonnell, Levi [1 ]
Adams, Katherine [1 ]
Gaglani, Manjusha [2 ,3 ]
Ginde, Adit A. [4 ]
Douin, David J. [4 ]
Talbot, H. Keipp [5 ]
Casey, Jonathan D. [5 ]
Mohr, Nicholas M. [6 ]
Zepeski, Anne [6 ]
McNeal, Tresa [3 ,4 ]
Ghamande, Shekhar [3 ,4 ]
Gibbs, Kevin W. [7 ]
Files, D. Clark [7 ]
Hager, David N. [8 ]
Shehu, Arber [8 ]
Frosch, Anne P. [9 ]
Erickson, Heidi L. [9 ]
Gong, Michelle N. [10 ]
Mohamed, Amira [10 ]
Johnson, Nicholas J. [11 ]
Srinivasan, Vasisht [11 ]
Steingrub, Jay S. [12 ]
Peltan, Ithan D. [13 ]
Brown, Samuel M. [13 ]
Martin, Emily T. [14 ]
Khan, Akram [15 ]
Bender, William S. [16 ]
Duggal, Abhijit [17 ]
Wilson, Jennifer G. [18 ]
Qadir, Nida [19 ]
Chang, Steven Y. [19 ]
Mallow, Christopher [20 ]
Rivas, Carolina [20 ]
Kwon, Jennie H. [21 ]
Exline, Matthew C. [22 ]
Lauring, Adam S. [23 ]
Shapiro, Nathan I. [24 ]
Halasa, Natasha [5 ]
Chappell, James D. [5 ]
Grijalva, Carlos G. [5 ]
Rice, Todd W. [5 ]
Stubblefield, William B. [5 ]
Baughman, Adrienne [5 ]
Womack, Kelsey N. [5 ]
Hart, Kimberly W. [5 ]
Swan, Sydney A. [5 ]
Zhu, Yuwei [5 ]
DeCuir, Jennifer [1 ]
Tenforde, Mark W. [1 ]
机构
[1] CDC COVID 19 Emergency Response Team, Atlanta, GA 30329 USA
[2] Baylor Scott & White Hlth, Temple, TX USA
[3] Texas A&M Univ, Coll Med, Temple, TX USA
[4] Univ Colorado, Sch Med, Aurora, CO USA
[5] Vanderbilt Univ Sch Med, Nashville, TN USA
[6] Univ Iowa, Iowa City, IA USA
[7] Wake Forest Univ, Baptist Med Ctr, Winston Salem, NC USA
[8] Johns Hopkins Univ Hosp, Baltimore, MD USA
[9] Hennepin Cty Med Ctr, Minneapolis, MN USA
[10] Albert Einstein Coll Med, Montefiore Healthcare Ctr, New York, NY USA
[11] Univ Washington, Sch Med, Seattle, WA USA
[12] Baystate Med Ctr, Springfield, MA USA
[13] Univ Utah, Intermt Med Ctr, Salt Lake City, UT USA
[14] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI USA
[15] Oregon Hlth & Sci Univ Hosp, Portland, OR USA
[16] Emory Univ, Sch Med, Atlanta, GA USA
[17] Cleveland Clin, Cleveland, OH USA
[18] Stanford Univ, Sch Med, Stanford, CA USA
[19] Ronald Reagan UCLAMed Ctr, Los Angeles, CA USA
[20] Univ Miami, Miami, FL USA
[21] Washington Univ, St Louis, MO USA
[22] Ohio State Univ, Wexner Med Ctr, Columbus, OH USA
[23] Univ Michigan, Sch Med, Ann Arbor, MI USA
[24] Beth Israel Deaconess Med Ctr, Boston, MA USA
来源
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:1327 / 1334
页数:8
相关论文
共 46 条
  • [31] Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19-Associated Hospitalization Among Adults with Previous SARS-CoV-2 Infection - United States, June 2021-February 2022
    Plumb, Ian D.
    Feldstein, Leora R.
    Barkley, Eric
    Posner, Alexander B.
    Bregman, Howard S.
    Hagen, Melissa Briggs
    Gerhart, Jacqueline L.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (15): : 549 - 555
  • [32] Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)
    Maeda, Haruka
    Saito, Nobuo
    Igarashi, Ataru
    Ishida, Masayuki
    Terada, Mayumi
    Masuda, Shingo
    Osawa, Ryosuke
    Hosokawa, Naoto
    Nakashima, Kei
    Kamura, Hiroshi
    Imura, Haruki
    Inoue, Hiroki
    Matsuzaka, Suguru
    Sugimoto, Yukihiro
    Kuwamitsu, Osamu
    Motohashi, Iori
    Morikawa, Toru
    Oda, Rentaro
    Hoshina, Yuiko
    Matono, Takashi
    Teshigahara, Osamu
    Sando, Eiichiro
    Asami, Sadaharu
    Kudo, Satoshi
    Akizuki, Noboru
    Muto, Yoshikazu
    Hayakawa, Tomoichiro
    Kishaba, Tomoo
    Ohara, Yasuji
    Kubo, Yoshinao
    Suzuki, Motoi
    Morimoto, Konosuke
    EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 213 - 225
  • [33] Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period-IVY Network, 19 US States, February 1, 2022-January 31, 2023
    DeCuir, Jennifer
    Surie, Diya
    Zhu, Yuwei
    Gaglani, Manjusha
    Ginde, Adit A.
    Douin, David J.
    Talbot, H. Keipp
    Casey, Jonathan D.
    Mohr, Nicholas M.
    McNeal, Tresa
    Ghamande, Shekhar
    Gibbs, Kevin W.
    Files, D. Clark
    Hager, David N.
    Phan, Minh
    Prekker, Matthew E.
    Gong, Michelle N.
    Mohamed, Amira
    Johnson, Nicholas J.
    Steingrub, Jay S.
    Peltan, Ithan D.
    Brown, Samuel M.
    Martin, Emily T.
    Monto, Arnold S.
    Khan, Akram
    Bender, William S.
    Duggal, Abhijit
    Wilson, Jennifer G.
    Qadir, Nida
    Chang, Steven Y.
    Mallow, Christopher
    Kwon, Jennie H.
    Exline, Matthew C.
    Lauring, Adam S.
    Shapiro, Nathan, I
    Columbus, Cristie
    Gottlieb, Robert
    Vaughn, Ivana A.
    Ramesh, Mayur
    Lamerato, Lois E.
    Safdar, Basmah
    Halasa, Natasha
    Chappell, James D.
    Grijalva, Carlos G.
    Baughman, Adrienne
    Womack, Kelsey N.
    Rhoads, Jillian P.
    Hart, Kimberly W.
    Swan, Sydney A.
    Lewis, Nathaniel
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2023, 72 (17): : 463 - 468
  • [34] Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022
    Thompson, Mark G.
    Natarajan, Karthik
    Irving, Stephanie A.
    Rowley, Elizabeth A.
    Griggs, Eric P.
    Gaglani, Manjusha
    Klein, Nicola P.
    Grannis, Shaun J.
    DeSilva, Malini B.
    Stenehjem, Edward
    Reese, Sarah E.
    Dickerson, Monica
    Naleway, Allison L.
    Han, Jungmi
    Konatham, Deepika
    McEvoy, Charlene
    Rao, Suchitra
    Dixon, Brian E.
    Dascomb, Kristin
    Lewis, Ned
    Levy, Matthew E.
    Patel, Palak
    Liao, I-Chia
    Kharbanda, Anupam B.
    Barron, Michelle A.
    Fadel, William F.
    Grisel, Nancy
    Goddard, Kristin
    Yang, Duck-Hye
    Wondimu, Mehiret H.
    Murthy, Kempapura
    Valvi, Nimish R.
    Arndorfer, Julie
    Fireman, Bruce
    Dunne, Margaret M.
    Embi, Peter
    Azziz-Baumgartner, Eduardo
    Zerbo, Ousseny
    Bozio, Catherine H.
    Reynolds, Sue
    Ferdinands, Jill
    Williams, Jeremiah
    Link-Gelles, Ruth
    Schrag, Stephanie J.
    Verani, Jennifer R.
    Ball, Sarah
    Ong, Toan C.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (04): : 139 - 145
  • [35] Neutralising antibody potency against SARS-CoV-2 wild-type and Omicron BA.1 and BA.4/5 variants in infliximab and vedolizumab treated patients with Inflammatory Bowel Disease after three doses of COVID-19 vaccine: a prospective multicentre cohort study
    Le, K.
    Zhou, X.
    Alexander, J.
    Lin, S.
    Bewshea, C.
    Chanchlani, N.
    Nice, R.
    McDonald, T.
    Lamb, C.
    Sebastian, S.
    Kok, K.
    Lees, C.
    Hart, A.
    Pollok, R.
    Boyton, R.
    Altmann, D.
    Pollock, K.
    Goodhand, J.
    Kennedy, N.
    Ahmad, T.
    Powell, N.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I32 - I34
  • [36] Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022
    Ferdinands, Jill M.
    Rao, Suchitra
    Dixon, Brian E.
    Mitchell, Patrick K.
    DeSilva, Malini B.
    Irving, Stephanie A.
    Lewis, Ned
    Natarajan, Karthik
    Stenehjem, Edward
    Grannis, Shaun J.
    Han, Jungmi
    McEvoy, Charlene
    Ong, Toan C.
    Naleway, Allison L.
    Reese, Sarah E.
    Embi, Peter J.
    Dascomb, Kristin
    Klein, Nicola P.
    Griggs, Eric P.
    Konatham, Deepika
    Kharbanda, Anupam B.
    Yang, Duck-Hye
    Fadel, William F.
    Grisel, Nancy
    Goddard, Kristin
    Patel, Palak
    Liao, I-Chia
    Birch, Rebecca
    Valvi, Nimish R.
    Reynolds, Sue
    Arndorfer, Julie
    Zerbo, Ousseny
    Dickerson, Monica
    Murthy, Kempapura
    Williams, Jeremiah
    Bozio, Catherine H.
    Blanton, Lenee
    Verani, Jennifer R.
    Schrag, Stephanie J.
    Dalton, Alexandra F.
    Wondimu, Mehiret H.
    Link-Gelles, Ruth
    Azziz-Baumgartner, Eduardo
    Barron, Michelle A.
    Gaglani, Manjusha
    Thompson, Mark G.
    Fireman, Bruce
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (07): : 255 - 263
  • [37] Neutralising antibody potency against SARS-CoV-2 wild- type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study
    Liu, Zhigang
    Le, Kaixing
    Zhou, Xin
    Alexander, James L.
    Lin, Simeng
    Bewshea, Claire
    Chanchlani, Neil
    Nice, Rachel
    McDonald, Timothy J.
    Lamb, Christopher A.
    Sebastian, Shaji
    Kok, Klaartje
    Lees, Charlie W.
    Hart, Ailsa L.
    Pollok, Richard C.
    Boyton, Rosemary J.
    Altmann, Daniel M.
    Pollock, Katrina M.
    Goodhand, James R.
    Kennedy, Nicholas A.
    Ahmad, Tariq
    Powell, Nick
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (02): : 145 - 156
  • [38] COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status-COVID-NET, 14 States, July 2021-January 2022
    Taylor, Christopher A.
    Whitaker, Michael
    Anglin, Onika
    Milucky, Jennifer
    Patel, Kadam
    Huong Pham
    Chai, Shua J.
    Alden, Nisha B.
    Yousey-Hindes, Kimberly
    Anderson, Evan J.
    Teno, Kenzie
    Reeg, Libby
    Como-Sabetti, Kathryn
    Bleecker, Molly
    Barney, Grant
    Bennett, Nancy M.
    Billing, Laurie M.
    Sutton, Melissa
    Talbot, H. Keipp
    McCaffrey, Keegan
    Havers, Fiona P.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (12): : 466 - 473
  • [39] Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, 18 October 2023-9 March 2024
    Ma, Kevin C.
    Surie, Diya
    Lauring, Adam S.
    Martin, Emily T.
    Leis, Aleda M.
    Papalambros, Leigh
    Gaglani, Manjusha
    Columbus, Christie
    Gottlieb, Robert L.
    Ghamande, Shekhar
    Peltan, Ithan D.
    Brown, Samuel M.
    Ginde, Adit A.
    Mohr, Nicholas M.
    Gibbs, Kevin W.
    Hager, David N.
    Saeed, Safa
    Prekker, Matthew E.
    Gong, Michelle Ng
    Mohamed, Amira
    Johnson, Nicholas J.
    Srinivasan, Vasisht
    Steingrub, Jay S.
    Khan, Akram
    Hough, Catherine L.
    Duggal, Abhijit
    Wilson, Jennifer G.
    Qadir, Nida
    Chang, Steven Y.
    Mallow, Christopher
    Kwon, Jennie H.
    Parikh, Bijal
    Exline, Matthew C.
    Vaughn, Ivana A.
    Ramesh, Mayur
    Safdar, Basmah
    Mosier, Jarrod
    Harris, Estelle S.
    Shapiro, Nathan, I
    Felzer, Jamie
    Zhu, Yuwei
    Grijalva, Carlos G.
    Halasa, Natasha
    Chappell, James D.
    Womack, Kelsey N.
    Rhoads, Jillian P.
    Baughman, Adrienne
    Swan, Sydney A.
    Johnson, Cassandra A.
    Rice, Todd W.
    CLINICAL INFECTIOUS DISEASES, 2024,
  • [40] Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5-and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults-Increasing Community Access to Testing Program, United States, December 2022-January 2023
    Link-Gelles, Ruth
    Ciesla, Allison Avrich
    Roper, Lauren E.
    Scobie, Heather M.
    Ali, Akilah R.
    Miller, Joseph D.
    Wiegand, Ryan E.
    Accorsi, Emma K.
    Verani, Jennifer R.
    Shang, Nong
    Derado, Gordana
    Britton, Amadea
    Smith, Zachary R.
    Fleming-Dutra, Katherine E.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2023, 72 (05): : 119 - 124